Trial intelligence / Profile preview

Melatonin versus midazolam for preoperative anxiety in cataract surgery

IRCT20190618043934N15Phase 3Completed

Sponsor
Vice Chancellor for Research, Birjand University of Medical Sciences
Start
Nov 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, open-label trial in cataract comparing Melatonin with Midazolam (2 arms). Primary endpoints: Preoperative anxiety and Intraoperative hemodynamic disorders. Started Nov 2022; status: completed.

02

Drugs

melatoninmidazolam
03

Conditions

cataract

Beyond the preview

Go deeper on IRCT20190618043934N15.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20190618043934N15.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call